Back to search

Article

Zavegepant intranasal spray for the Acute Treatment of Migraine : A Systematic Review and Meta-Analysis of Randomized Clinical Trials

2023-08-02

Abstract excerpt

<title>Abstract</title> <p>Migraine is a prevalent and debilitating primary headache disorder with significant socio-economic and personal impacts. This study aims to evaluate the safety and efficacy of zavegepant, a recently approved third-generation small-molecule calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray (BHV-3500), ), to be administered as a nasal spray in the acute treatment of m...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5af5c21f-62fb-5200-bf19-3f2fe9ff2fc1
DOI
10.21203/rs.3.rs-3215981/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Zavegepant intranasal spray for the Acute Treatment of Migraine : A Systematic Review and Meta-Analysis of Randomized Clinical TrialsDOI 10.21203/rs.3.rs-3215981/v1
Select a neighboring publication to make it the new centre.